CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net income/(loss)	$ 1,663	$ (3,119)
Depreciation and tooling amortization	1,897	1,857
Other amortization	(272)	(310)
Provision for/(Benefit from) credit losses and insurance losses	83	(66)
Pension and other postretirement employee benefits (“OPEB”) expense/(income) (Note 13)	303	(213)
Equity method investment dividends received in excess of (earnings)/losses and impairments	(7)	199
Foreign currency adjustments	(94)	32
Net realized and unrealized (gains)/losses on cash equivalents, marketable securities, and other investments	51	5,454
Net (gain)/loss on changes in investments in affiliates	(4)	125
Stock compensation	100	67
Provision for/(Benefit from) deferred income taxes	17	(1,053)
Decrease/(Increase) in finance receivables (wholesale and other)	(656)	(2,192)
Decrease/(Increase) in accounts receivable and other assets	(732)	(956)
Decrease/(Increase) in inventory	(1,967)	(2,755)
Increase/(Decrease) in accounts payable and accrued and other liabilities	2,323	1,714
Other	95	132
Net cash provided by/(used in) operating activities	2,800	(1,084)
Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]
Capital spending	(1,780)	(1,370)
Acquisitions of finance receivables and operating leases	(12,543)	(10,278)
Collections of finance receivables and operating leases	11,170	11,988
Purchases of marketable securities and other investments	(2,545)	(4,319)
Sales and maturities of marketable securities and other investments	4,413	7,115
Settlements of derivatives	(41)	212
Payments to Acquire Equity Method Investments	(699)	(25)
Other	48	(8)
Net cash provided by/(used in) investing activities	(1,977)	3,315
Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]
Cash payments for dividends and dividend equivalents	(3,193)	(405)
Purchases of common stock	0	0
Net changes in short-term debt	(2,211)	(614)
Proceeds from issuance of long-term debt	13,912	12,489
Payments of long-term debt	(12,242)	(12,975)
Other	(140)	(156)
Net cash provided by/(used in) financing activities	(3,874)	(1,661)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect [Abstract]
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	70	(24)
Net increase/(decrease) in cash, cash equivalents, and restricted cash	(2,981)	546
Cash, cash equivalents, and restricted cash at beginning of period (Note 7)	25,340	20,737
Cash, cash equivalents, and restricted cash at end of period (Note 7)	$ 22,359	$ 21,283